TELA Bio to Participate in the JMP Securities Life Sciences Conference

MALVERN, Pa., May 02, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy, today announced that the Company will participate in the JMP Securities Life Sciences Conference on Monday, May 15^th, 2023.

TELA’s management is scheduled to present at 12:00 pm ET on May 15^th, 2023. Interested parties can access the live and archived webcast at ir.telabio.com.

About TELA Bio, Inc.

TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient’s natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit www.telabio.com.

Investor Contact
Greg Chodaczek
347-620-7010
[email protected]

You May Also Be Interested In

• RadiusXR and Topcon Healthcare Inc. Introduce InspirePRO: The New Standard in Visual Field Testing
• Ethereum News: New Execution-Proof Proposal Could Reshape Network Security Before RTX Launch
• TechMediaBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) Brings GPS-Independent Intelligence to Drones and Autonomous Platforms